Skip to main content

Child & Adolescent Psychiatry

Up to 2 years of treatment with lurasidone improved manic symptoms in children and adolescents with bipolar depression, according to a poster presented at Psych Congress 2020.
Clinicians could be on the brink of a much greater understanding of the relatively new diagnosis of disruptive mood dysregulation disorder (DMDD) in children, including evidence on the most promising direction in treatment, Julie Carbray, PhD, PMHNP…
Daily social media use is neither a strong nor consistent risk factor for depressive symptoms in adolescents in the United States, according to a new study published in the Journal of Adolescent Health.
In this installment of "Coping During COVID-19," Psych Congress Steering Committee member Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, shares tips and learnings for treating children and adolescents via telepsychiatry.
Psych Congress Steering Committee member Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, discusses aspects of the COVID-19 pandemic which may have long-term mental health consequences for children and adolescents.
Back to Top